Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy (IMMC-38)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Immunicon.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Immunicon
Information provided by:
Immunicon
ClinicalTrials.gov Identifier:
NCT00133900
First received: August 22, 2005
Last updated: July 27, 2009
Last verified: March 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2009 |
| Estimated Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
No publications provided by Immunicon
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):